Skip to main content

Day: April 1, 2024

Integra LifeSciences Completes the Acquisition of Acclarent, Inc.

PRINCETON, N.J., April 01, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed its acquisition of Acclarent, Inc., a pioneer in ear, nose and throat (ENT) surgical interventions. The addition of Acclarent’s innovative product portfolio expands the breadth of Integra’s market-leading brands and provides immediate scale and accretive growth via a dedicated sales channel. The acquisition adds $1 billion to the total addressable market of the Company’s offerings, while providing unique market opportunities for access to the attractive ENT device segment. “Acclarent’s strong commercial capabilities, R&D expertise, advanced portfolio and deep clinical knowledge will be important assets to Integra, enabling...

Continue reading

AppTech Payments Corp. Reports Fiscal Year 2023 Results

CARLSBAD, Calif., April 01, 2024 (GLOBE NEWSWIRE) — AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, disclosed its financial outcomes for the fiscal year ended December 31, 2023. Comprehensive financial details and the 10-K report are accessible on the SEC website at www.sec.gov. Fiscal Year 2023 Financial Highlight Revenue was approximately $504 thousand for the year ended December 31, 2023, compared to $450 thousand for the year ended December 31, 2022, representing an increase of 12%. The increase was principally driven by the new licensing revenue and offset by lower merchant processing revenue.Recent Business Highlights Entered a strategic partnership to build, develop, launch, and manage InstaCash, Inc.’s mobile-to-mobile payment system, and subsequently extended the...

Continue reading

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya™ for fibromyalgia for NDA submission second half of 2024; pre-NDA meeting with FDA scheduled for second quarter 2024 Commercial planning underway, including go-to-market, supply chain and manufacturing strategies, for U.S. launch of Tonmya, a potential new first-line, centrally-acting, non-opioid analgesic for the management of fibromyalgia CHATHAM, N.J., April 01, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an overview of recent operational highlights. “Our...

Continue reading

Whitestone REIT Announces First Quarter 2024 Earnings Webcast and Conference Call

HOUSTON, April 01, 2024 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE:WSR) (“Whitestone” or the “Company”) today announced that it will release its financial results for the first quarter ended March 31, 2024 after the market close on Wednesday, May 1, 2024. The Company will host a webcast and conference call to discuss the results on Thursday, May 2, 2024, at 8:30 A.M. Eastern Time. The call will be led by Dave Holeman, Chief Executive Officer. The webcast and conference call access information is as follows:Dial-in number for domestic participants: 1-877-407-0784Dial-in number for international participants: 1-201-689-8560Passcode: 13742562The conference call will be recorded, and a telephone replay will be available through May 16, 2024. Replay access information is as follows:Replay number for domestic participants: 1-844-512-2921Replay...

Continue reading

ARMOUR Residential REIT, Inc. Confirms April 2024 Common Share and Series C Preferred Share Dividends

VERO BEACH, Florida, April 01, 2024 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today confirmed the April 2024 cash dividend for the Company’s Common Stock consistent with the previous guidance which the Company released on March 25, 2024. The Company also confirmed the Q2 2024 monthly cash dividend rate for the Company’s Series C Preferred Stock. April 2024 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateApril 2024   $0.24   April 15, 2024   April 29, 2024 Q2 2024 Series C Preferred Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateApril 2024   $0.14583   April 15, 2024   April 29, 2024May 2024   $0.14583   May 15, 2024   May 28, 2024June 2024   $0.14583   June 15,...

Continue reading

GAMCO Expects to Report Diluted EPS for the First Quarter 2024 of $0.61 to $0.67 Per Share

GREENWICH, Conn., April 01, 2024 (GLOBE NEWSWIRE) — GAMCO Investors, Inc. (“GAMI”) (OTCQX: GAMI) announced today that assets under management were $32.4 billion at March 31, 2024 as compared to $30.7 billion at March 31, 2023. GAMI expects to report first quarter 2024 diluted earnings in the range of $0.61 to $0.67 per share versus $0.62 per share for the first quarter of 2023. GAMI will be issuing further details on its financial results in early May. About GAMCO Investors, Inc. GAMI is known for its research-driven value approach to equity investing (known as PMV with a Catalyst™). GAMI conducts its investment advisory business principally through two subsidiaries: Gabelli Funds, LLC (24 open-end funds, 14 closed-end funds, 5 actively managed semi-transparent ETFs, and a SICAV) and GAMCO Asset Management Inc. (approximately...

Continue reading

Atlantic American Corporation Reports Fourth Quarter and Year End Results for 2023; Declares Annual Dividend

ATLANTA, April 01, 2024 (GLOBE NEWSWIRE) — Atlantic American Corporation (Nasdaq- AAME) today reported net loss for the three month period ended December 31, 2023 of $2.2 million, or ($0.11) per diluted share, as compared to net income of $1.0 million, or $0.05 per diluted share, for the comparable period in 2022. For the year ended December 31, 2023, the Company reported net loss of $0.2 million, or ($0.03) per diluted share, as compared to net income of $1.5 million, or $0.06 per diluted share, for the year ended December 31, 2022. The decrease in net income for the fourth quarter of 2023 was primarily due to an increase in insurance benefits and losses incurred partially offset by an increase in unrealized gains in equity securities. The decrease in net income for the year ended December 31, 2023 was primarily due to a decrease...

Continue reading

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023.  Dr. Hing C. Wong, Founder and CEO of HCW Biologics, stated, “These are exciting times at HCW Biologics. We achieved two major clinical milestones, with the completion of the Phase 1 clinical study to evaluate HCW9218 in solid tumors and the Phase 1b study to evaluate HCW9218 in pancreatic cancer. While it is still quite early in the clinical development process and we have only seen data when...

Continue reading

Motorsport Games Reports Fourth Quarter & Full Year 2023 Financial Results

Motorsport Games Reports Fourth Quarter & Full Year 2023 Financial ResultsMotorsport Games Reports Fourth Quarter & Full Year 2023 Financial ResultsMIAMI, April 01, 2024 (GLOBE NEWSWIRE) — Motorsport Games Inc. (NASDAQ: MSGM) (“Motorsport Games” or the “Company”) today reported financial results for its fourth quarter and fiscal year ended December 31, 2023. The Company has also posted the fourth quarter and fiscal year-end 2023 earnings slides highlighting key milestones that occurred in the period, which are accessible on the Company’s investor relations website. “2023 was a year of repositioning. Reducing costs, headcount and projects allowed us to focus on what we know best, making innovative games. Having determined the correct direction for the company, we put our energy into Le Mans Ultimate, an innovative...

Continue reading

Shenandoah Telecommunications Company Completes Acquisition of Horizon Telcom

EDINBURG, Va., April 01, 2024 (GLOBE NEWSWIRE) —  Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced today the completion of its acquisition of Horizon Acquisition Parent LLC (“Horizon” or “Horizon Telcom”). Horizon is a leading commercial fiber provider in Ohio and adjacent states serving national wireless providers, carriers, enterprises, and government, education and healthcare customers. Horizon’s unique fiber network is the largest and most dense network across its footprint, and the combined company will have approximately 15,4001 fiber route miles across seven adjacent states. Shentel plans to re-brand the Horizon commercial and residential fiber businesses to Glo Fiber. “We are excited to expand into Ohio and Indiana, roughly doubling the size of our commercial fiber business, adding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.